Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Groundhog Quarter
View:
Post by riverrrow on Nov 30, 2023 8:42am

Groundhog Quarter

It looks like we're stuck in a version of Bill Murray's movie Groundhog Day called Groundhog Quarter.  Once a quarter us TLT shareholders unwillingly stick our heads out of the ground and we see there's still no BTD for us.  Next quarter, next quarter, we mutter as we go back to sleep.  A restless sleep of dreaming of increasing CRs, JV's, pp's, BTD and AA. It all seems so real but of course it's all an illusion.  GLTA.
Comment by Rumpl3StiltSkin on Nov 30, 2023 10:25am
With BTD does anyone think they wont be able to get another PP? And, also the improving data by then should put the heat on any potential jv partners? We all think they have potential partners in mind, right?? And all with AA looming, creating a strong negotiation point for TLT and a fast payout for the deal once the partnership is signed.
Comment by Sunvalley on Nov 30, 2023 10:58am
Thank you Rump for injecting some realism into the conversation.And also enriquesuave for again highlighting the stellar CR stasticics. Let keep things in perspective here OK folks? As pointed out the CR numbers are without equal and are improving to boot so give your head a shake if you think that with BTD and AA in hand  TLT wont be able to raise tons of money easily. I know that it is ...more  
Comment by anabelsi on Nov 30, 2023 11:25am
"I was about ready to go out and wrap my lips around the tailpipe of my wifes car" This made me laugh way too hard lol Yeah I guess I have been too negative lately, I am just worried. Sorry all
Comment by StevenBirch on Nov 30, 2023 1:35pm
My two takeaways are the numbers are really good vs the competition and getting better and we don't really know the back and forth between TLT and the FDA. Some people want the minutiae but I don't think we need that or are entitled to that. They have submitted a pre-BTD, were asked for clarifications, are in the process of making those clarifications and will soon be re-submitting the pre ...more  
Comment by DeathXray33 on Dec 01, 2023 10:54am
My order filled today... I'm buying more Monday...
Comment by N0taP00p on Nov 30, 2023 11:23am
LOL.  Couldn't have described it better.  I've been offloading shares this week. About 15% of holdings for end of year.    Like I expected and said, BTD is now Q1. I have no doubt they'll need money again sometime in January or early February. No update on vaccines, so I'm assuming that revenue stream won't materialize anytime soon.  Holding on to the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250